专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06822953B1 Method for transmitting radio signals and receiver for receiving radio signals 失效
标题翻译：用于发送无线电信号的方法和用于接收无线电信号的接收机
公开(公告)号：US06822953B1
公开(公告)日：2004-11-23
申请号：US09590399
申请日：2000-06-08
申请人： Wolfgang Schaefer , Frank Hofmann , Christian Hansen
发明人： Wolfgang Schaefer , Frank Hofmann , Christian Hansen
IPC分类号： H04B7208
CPC分类号： H04B7/12 , H04H20/22
摘要： A method for transmitting radio signals and a receiver for receiving radio signals are described which are used to present a radio station which is transmitted on multiple frequencies with the data on the frequency that has the best signal quality. Via received radio signals the receiver is provided a list of all the frequencies on which radio stations are transmitted, the receiver checking each frequency to determine whether the frequency belongs to the radio station selected by the user and whether the signal quality is better than that which is used for the presentation of the radio station. Test symbols having pilots and useful data signals are used to determine the signal quality. An identification number for the radio station is determined from the useful data signals of the test symbols before the signal quality is checked and a channel estimate is made via the pilots. The test symbols are modulated with coherent QPSK. A test symbol is recognized in the data flow by a different protective interval.
摘要翻译：描述用于发送无线电信号的方法和用于接收无线电信号的接收机，其用于呈现在具有最佳信号质量的频率上的数据在多个频率上发送的无线电台。通过接收到的无线电信号，接收机被提供了发射无线电台的所有频率的列表，接收机检查每个频率以确定频率是否属于用户选择的无线电台，以及信号质量是否优于用于演播无线电台。使用具有导频和有用数据信号的测试符号来确定信号质量。在检查信号质量之前，从测试符号的有用数据信号确定无线电台的识别号，并且经由导频进行信道估计。测试符号用相干QPSK调制。在数据流中以不同的保护间隔识别测试符号。

2. 发明授权

US07339882B2 Method for frame and frequency synchronization of an OFDM signal and method for transmitting an OFDM signal 有权
标题翻译：用于OFDM信号的帧和频率同步的方法以及用于发送OFDM信号的方法
公开(公告)号：US07339882B2
公开(公告)日：2008-03-04
申请号：US10473631
申请日：2002-03-15
申请人： Wolfgang Schaefer , Christian Hansen
发明人： Wolfgang Schaefer , Christian Hansen
IPC分类号： H04J11/00
CPC分类号： H04L1/0056 , H04L1/0071 , H04L27/2656 , H04L27/2657 , H04L27/2675
摘要： A method for frame and frequency synchronization of an OFDM signal and a signal for transmitting an OFDM signal is described, the purpose of which is to impress a pilot phase profile that is then used at the receiving end for frame and frequency synchronization on pilots which are already contained in the OFDM signal for channel estimation. This has the advantage that no additional transmission capacity has to be used for the synchronization. The method according to the present invention is initiated by a rough time synchronization unit connected upline, which searches for the beginning of the guard interval in the OFDM signal. The comparison between a stored pilot phase profile and the received subcarrier symbol is performed using a cross-correlation, whose result is then evaluated to determine the frame and frequency synchronization.
摘要翻译：描述了一种用于OFDM信号的帧和频率同步的方法和用于发送OFDM信号的信号的方法，其目的是在导频上施加导频相位分布，该导频相位分布在接收端被用于帧和频率同步，已经包含在OFDM信号中用于信道估计。这具有不需要用于同步的附加传输容量的优点。根据本发明的方法由连续上行的粗略的时间同步单元启动，其在OFDM信号中搜索保护间隔的开始。使用互相关来执行存储的导频相位轮廓和接收的副载波符号之间的比较，然后对其结果进行评估以确定帧和频率同步。

3. 发明授权

US08945552B2 Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies 有权
标题翻译：双特异性，二价抗VEGF /抗ANG-2抗体
公开(公告)号：US08945552B2
公开(公告)日：2015-02-03
申请号：US13071127
申请日：2011-03-24
申请人： Monika Baehner , Sabine Imhof-Jung , Anita Kavlie , Hubert Kettenberger , Christian Klein , Joerg Thomas , Wolfgang Schaefer , Kay-Gunnar Stubenrauch , Markus Thomas
发明人： Monika Baehner , Sabine Imhof-Jung , Anita Kavlie , Hubert Kettenberger , Christian Klein , Joerg Thomas , Wolfgang Schaefer , Kay-Gunnar Stubenrauch , Markus Thomas
IPC分类号： A61K39/395 , C07K16/22 , A61K39/00
CPC分类号： C07K16/22 , A61K2039/505 , C07K16/3015 , C07K16/3046 , C07K16/468 , C07K2317/31 , C07K2317/35 , C07K2317/52 , C07K2317/522 , C07K2317/56 , C07K2317/66 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要： The present invention relates to bispecific, bivalent antibodies against human vascular endothelial growth factor (VEGF/VEGF-A) and against human angiopoietin-2 (ANG-2), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
摘要翻译：本发明涉及针对人血管内皮生长因子（VEGF / VEGF-A）和针对人血管生成素-2（ANG-2）的双特异性二价抗体，其生产方法，含有所述抗体的药物组合物及其用途。

4. 发明授权

US08835530B2 UV-curing glass printing ink and UV-curing glass printing lacquer and process for printing glass substrates 有权
标题翻译： UV固化玻璃印刷油墨和UV固化玻璃印刷漆和印刷玻璃基板的工艺
公开(公告)号：US08835530B2
公开(公告)日：2014-09-16
申请号：US11649728
申请日：2007-01-04
申请人： Wolfgang Schaefer , Dimitrios Triantafillidis
发明人： Wolfgang Schaefer , Dimitrios Triantafillidis
IPC分类号： C09D11/10 , C09D11/02 , C08J3/28 , C08F2/46 , C08F2/50
CPC分类号： C09D11/101 , C03C17/326
摘要： A glass printing ink and glass printing lacquer are prepared, which contain at least one photoinitiator, at least one resin and at least one additional substance. The resin is an epoxy resin based on bisphenol A, diluted in a UV-curing monomer, or a resin with functional groups containing free functional amino, hydroxy, epoxy, acid, acid anhydride and/or acrylate groups, or a combination of the epoxy resin with the resin with functional groups. The at least one additional substance is a wax. The use of the glass printing ink and glass printing lacquer in printing a glass substrate and processes for the printing of a glass substrate are also described.
摘要翻译：制备玻璃印刷油墨和玻璃印刷漆，其含有至少一种光引发剂，至少一种树脂和至少一种另外的物质。树脂是基于双酚A的环氧树脂，其在UV固化单体中稀释，或具有含有游离官能氨基，羟基，环氧，酸，酸酐和/或丙烯酸酯基团的官能团的树脂，或环氧树脂树脂与树脂与官能团。至少一种另外的物质是蜡。还描述了在印刷玻璃基板中使用玻璃印刷油墨和玻璃印刷漆以及印刷玻璃基板的方法。

5. 发明授权

US08058283B2 7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors 失效
标题翻译： 7H-吡啶并[3,4-D]嘧啶-8-酮，其制备和用作蛋白激酶抑制剂
公开(公告)号：US08058283B2
公开(公告)日：2011-11-15
申请号：US12087420
申请日：2007-01-29
申请人： Konrad Honold , Jane Paul , Carl Roeschlaub , Wolfgang Schaefer , Stefan Scheiblich , Thomas Von Hirschheydt , Alan Whittle
发明人： Konrad Honold , Jane Paul , Carl Roeschlaub , Wolfgang Schaefer , Stefan Scheiblich , Thomas Von Hirschheydt , Alan Whittle
IPC分类号： C07D471/04 , A61K31/519 , A61P29/00 , A61P35/00 , A61P5/22 , A61P37/00 , A61P25/00
CPC分类号： C07D471/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
摘要翻译：本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物及其制备，以及上述化合物在对照或预防癌症等疾病。

6. 发明申请

US20100254988A1 Bispecific Anti ErbB2 / Anti cMet Antibodies 审中-公开
标题翻译：双特异性抗ErbB2 /抗cMet抗体
公开(公告)号：US20100254988A1
公开(公告)日：2010-10-07
申请号：US12753141
申请日：2010-04-02
申请人： Birgit Bossenmaier , Ulrich Brinkmann , Christian Klein , Gerhard Niederfellner , Wolfgang Schaefer , Juergen Michael Schanzer , Claudio Sustmann , Pablo Umana
发明人： Birgit Bossenmaier , Ulrich Brinkmann , Christian Klein , Gerhard Niederfellner , Wolfgang Schaefer , Juergen Michael Schanzer , Claudio Sustmann , Pablo Umana
IPC分类号： A61K39/395 , C07K16/28 , C07H21/04 , A61P35/00
CPC分类号： C07K16/468 , A61K2039/505 , C07K16/2863 , C07K16/32 , C07K2317/24 , C07K2317/31 , C07K2317/41 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/73 , C07K2317/76 , C07K2317/77 , C07K2317/92 , C07K2319/00
摘要： The present invention relates to bispecific antibodies against human ErbB-2 and against human c-Met, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof.
摘要翻译：本发明涉及针对人ErbB-2和针对人c-Met的双特异性抗体，其制备方法，含有抗体的药物组合物及其用途。

7. 发明授权

US07786113B2 Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents 失效
标题翻译：杂环氨基甲酸酯衍生物，其制造和用作药剂
公开(公告)号：US07786113B2
公开(公告)日：2010-08-31
申请号：US11793750
申请日：2005-12-22
申请人： Konrad Honold , Klaus Kaluza , Birgit Masjost , Wolfgang Schaefer , Stefan Scheiblich
发明人： Konrad Honold , Klaus Kaluza , Birgit Masjost , Wolfgang Schaefer , Stefan Scheiblich
IPC分类号： A61K31/5377 , A61K31/44 , C07D413/14 , C07D471/02
CPC分类号： C07D471/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译：本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物控制或预防癌症等疾病。

8. 发明申请

US20100041684A1 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS 失效
标题翻译：作为蛋白激酶抑制剂的吡咯烷衍生物
公开(公告)号：US20100041684A1
公开(公告)日：2010-02-18
申请号：US12444592
申请日：2007-12-19
申请人： Guy Georges , Matthias Koerner , Irene Kolm , Ulrike Reiff , Wolfgang Schaefer , Edgar Voss , Stefan Weigand
发明人： Guy Georges , Matthias Koerner , Irene Kolm , Ulrike Reiff , Wolfgang Schaefer , Edgar Voss , Stefan Weigand
IPC分类号： A61K31/505 , C07D239/47 , C07D239/56
CPC分类号： C07D239/47 , C07D405/12
摘要： Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
摘要翻译：本发明的目的是式（I）的化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物及其制备，以及上述化合物在控制或预防癌症等疾病。

9. 发明申请

US20090247518A1 6-(2-ALKYL-PHENYL)-PYRIDO[2,3-D]PYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：用作蛋白激酶抑制剂的6-（2-烷基 - 苯基） - 吡咯并[2,3-D]嘧啶
公开(公告)号：US20090247518A1
公开(公告)日：2009-10-01
申请号：US12411778
申请日：2009-03-26
申请人： Konrad Honold , Wolfgang Schaefer , Stefan Scheiblich
发明人： Konrad Honold , Wolfgang Schaefer , Stefan Scheiblich
IPC分类号： A61K31/5377 , C07D471/04 , A61K31/519 , A61P35/00
CPC分类号： C07D471/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译：本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物控制或预防癌症等疾病。

10. 发明申请

US20090227578A1 Azabenzimidazole Derivatives, Their Manufacture and Use as Anti-Cancer Agents 审中-公开
标题翻译：氮杂苯并咪唑衍生物，其制造和用作抗癌剂
公开(公告)号：US20090227578A1
公开(公告)日：2009-09-10
申请号：US11988813
申请日：2006-07-28
申请人： Richard Engh , Hubert Hertenberger , Konrad Honold , Birgit Masjost , Petra Rueger , Wolfgang Schaefer , Stefan Scheiblich , Manfred Schwaiger
发明人： Richard Engh , Hubert Hertenberger , Konrad Honold , Birgit Masjost , Petra Rueger , Wolfgang Schaefer , Stefan Scheiblich , Manfred Schwaiger
IPC分类号： A61K31/5377 , C07D471/04 , A61K31/437
CPC分类号： C07D471/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译：本发明的目的是式I化合物，其药学上可接受的盐，对映异构体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物组合物及其制备方法以及使用上述控制或预防疾病如癌症的化合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式